Absorption |
Blood-Brain Barrier | BBB+ | 0.9628 |
Human Intestinal Absorption | HIA+ | 1.0000 |
Caco-2 Permeability | Caco2+ | 0.8149 |
P-glycoprotein Substrate | Substrate | 0.6597 |
P-glycoprotein Inhibitor | Inhibitor | 0.7113 |
Non-inhibitor | 0.8526 |
Renal Organic Cation Transporter | Non-inhibitor | 0.7227 |
Distribution |
Subcellular localization | Mitochondria | 0.8842 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8331 |
CYP450 2D6 Substrate | Non-substrate | 0.9308 |
CYP450 3A4 Substrate | Substrate | 0.7530 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.9046 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9443 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9410 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9025 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8500 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9027 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9479 |
Non-inhibitor | 0.7566 |
AMES Toxicity | Non AMES toxic | 0.9311 |
Carcinogens | Non-carcinogens | 0.9537 |
Fish Toxicity | High FHMT | 0.9899 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.8811 |
Honey Bee Toxicity | High HBT | 0.8111 |
Biodegradation | Not ready biodegradable | 0.9630 |
Acute Oral Toxicity | IV | 0.6428 |
Carcinogenicity (Three-class) | Non-required | 0.4609 |